MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing advanced cancer therapies aimed at improving patient outcomes across a variety of cancer types. Utilizing its proprietary technology platforms, MAIA is committed to creating novel drug candidates that harness the immune system to target tumors, addressing significant unmet needs in oncology. With a strong pipeline and a strategic approach to therapeutic development, the company aims to play a crucial role in the biopharmaceutical sector, capitalizing on growth opportunities within the expanding healthcare market.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

444 WEST LAKE STREET, CHICAGO, IL, UNITED STATES, 60606

December

$82.5 Million

$0.00

0.0

-0.74

$0.00

0.0%

0.316